A & G Pharmaceutical Inc
At A&G Pharmaceutical, we’re ushering in a more personalized approach to the treatment of cancer and other serious diseases by harnessing the power of antibodies to selectively recognize and latch on to the specific cell-surface biomarkers that distinguish diseased cells from normal cells. Using the tumor-specific biomarkers as targets, we are engineering a new generation of therapeutics that selectively strike the causes of tumor growth, while concurrently developing FDA-approved “companion” diagnostic tests that reliably reveal the specific cancer long before it reveals itself, identify patients that will respond to the associated targeted therapy, predict recurrence, and monitor response to treatment.